Genotyping of alleles from tail samples.
Ended Awarded Last action
- Contract number
- 75N91018F00001
- Awardee
-
Transnetyx, Inc. UEI CNG6DGADGL38
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,176
Award facts
- Contract value 100% obligated
- $6,176.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Cordova, TN 38016, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$8,759 | |
| Original award | $14,935 |
About this award
The National Cancer Institute awarded a $6,176 firm fixed-price blanket purchase agreement call to Transnetyx, Inc. for genotyping of alleles from tail samples. The contract was executed on August 17, 2018, with an ultimate completion date of March 14, 2023, and performance is based in Cordova, Tennessee. This award utilized no set-aside designation, indicating open market competition. The contract was issued to de-obligate expiring fiscal year 2018 funds in accordance with NIH Office of Acquisition and Logistics Management communication 23-18.
Transnetyx, Inc. is a specialized genetic testing services provider headquartered in Cordova, Tennessee, with established expertise in genomic analysis for federal research institutions. The company maintains substantial Indefinite Delivery Vehicles with multiple National Institutes of Health components and the Department of Veterans Affairs, including a $10 million Blanket Purchase Agreement with the Office of Logistics and Acquisition Operations and a $7 million Indefinite Delivery Contract with the National Institute of Environmental Health Sciences. Through its extensive history of federal contracting since 2007, Transnetyx has demonstrated consistent capability in delivering precise genetic analysis services supporting critical scientific research across neurology, environmental health, aging, and substance abuse research domains.
Quick answers
Who was awarded contract 75N91018F00001?
75N91018F00001 was awarded to Transnetyx, Inc. by National Cancer Institute (National Institutes of Health) on August 17, 2018.
How much is contract 75N91018F00001 worth?
The government has obligated $6,176 on 75N91018F00001.
Is contract 75N91018F00001 an order under another contract?
Yes. 75N91018F00001 is a BPA call under HHSN263201100002B, a blanket purchase agreement.
Was contract 75N91018F00001 competed?
The extent of competition for 75N91018F00001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award